Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Microsoft
MSFT
|
+$633M |
| 3 |
Alibaba
BABA
|
+$501M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$484M |
| 5 |
Apple
AAPL
|
+$456M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$622M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$597M |
| 3 |
Comcast
CMCSA
|
+$461M |
| 4 |
UnitedHealth
UNH
|
+$409M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$343M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.08% |
| 2 | Consumer Discretionary | 2.25% |
| 3 | Financials | 2.23% |
| 4 | Healthcare | 2.22% |
| 5 | Industrials | 1.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMA
1601
ImageneBio Inc
IMA
$66.3M
| $26.8M | 0.01% |
177,257
-2,461
| -1% | -$358K |
|
1602
Cardinal Health
CAH
$54.1B
| $26.8M | 0.01% |
541,499
+180,285
| +50% | +$9.78M |
|
1603
CALL
Sony
SONY
$142B
| $26.8M | 0.01% |
1,211,000
+301,500
| +33% | +$6.31M |
|
1604
CALL
Copart
CPRT
$29.3B
| $26.8M | 0.01% |
772,000
+207,200
| +37% | +$7.4M |
|
1605
CALL
Nutrien
NTR
$32.5B
| $26.7M | 0.01% |
412,100
+40,300
| +11% | +$2.46M |
|
1606
CALL
Ecolab
ECL
$77.5B
| $26.7M | 0.01% |
128,000
+54,800
| +75% | +$12M |
|
1607
CALL
Illinois Tool Works
ITW
$82.7B
| $26.7M | 0.01% |
129,200
+24,400
| +23% | +$5.5M |
|
1608
Tandem Diabetes Care
TNDM
$1.57B
| $26.6M | 0.01% |
223,116
-174,268
| -44% | -$19.2M |
|
1609
PUT
Credit Acceptance
CACC
$6.09B
| $26.6M | 0.01% |
45,500
+7,200
| +19% | +$3.92M |
|
1610
Kimco Realty
KIM
$16.4B
| $26.6M | 0.01% |
1,282,627
+1,242,964
| +3,134% | +$26.6M |
|
1611
Abercrombie & Fitch
ANF
$4.85B
| $26.6M | 0.01% |
706,299
+95,473
| +16% | +$3.69M |
|
|
KNTE
1612
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $26.6M | 0.01% |
1,154,273
-146,614
| -11% | -$3.19M |
|
1613
BlackBerry
BB
$5.23B
| $26.6M | 0.01% |
2,729,360
+5,229
| +0.2% | +$54.8K |
|
1614
Procore
PCOR
$9.04B
| $26.5M | 0.01% |
296,644
+43,206
| +17% | +$4.07M |
|
1615
PUT
PPG Industries
PPG
$25.4B
| $26.5M | 0.01% |
185,200
+101,600
| +122% | +$16.3M |
|
|
PDCO
1616
DELISTED
Patterson Companies, Inc.
PDCO
| $26.5M | 0.01% |
878,266
+598,519
| +214% | +$18.2M |
|
1617
CALL
Bausch Health
BHC
$2.42B
| $26.5M | 0.01% |
950,100
-271,500
| -22% | -$7.7M |
|
1618
Consolidated Edison
ED
$40.3B
| $26.4M | 0.01% |
364,196
-294,978
| -45% | -$22M |
|
|
FTCH
1619
CALL
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $26.4M | 0.01% |
704,500
+279,300
| +66% | +$12.4M |
|
1620
Laureate Education
LAUR
$5.16B
| $26.4M | 0.01% |
1,551,390
+1,482,863
| +2,164% | +$23.3M |
|
|
ITOS
1621
DELISTED
iTeos Therapeutics
ITOS
| $26.3M | 0.01% |
975,418
-18,978
| -2% | -$496K |
|
|
LKFT
1622
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.81B
| $26.3M | 0.01% |
500,218
+47,039
| +10% | +$2.79M |
|
1623
PUT
PagSeguro Digital
PAGS
$2.4B
| $26.3M | 0.01% |
508,600
+27,700
| +6% | +$1.55M |
|
|
GAP
1624
CALL
The Gap Inc
GAP
$7.45B
| $26.3M | 0.01% |
1,157,100
-115,300
| -9% | -$3.18M |
|
1625
CALL
L3Harris
LHX
$54.4B
| $26.3M | 0.01% |
119,200
+35,600
| +43% | +$8.1M |
|
Similar funds
Ken Griffin's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.
- Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
- Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
- Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
- Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
- Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
- Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
- Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.
Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.